(Q43704735)

26 November 2017

AAV-BDNF mediated attenuation of quinolinic acid-induced neuropathology and motor function impairment (English)

1 reference

26 November 2017

B Connor

3

0 references

author name string

A P Kells

series ordinal

1

1 reference

PubMed ID

18323792

26 November 2017

R A Henry

series ordinal

2

1 reference

26 November 2017

6 March 2008

1 reference

26 November 2017

1 reference

26 November 2017

15

1 reference

26 November 2017

13

1 reference

26 November 2017

966-977

1 reference

https://scigraph.springernature.com/pub.10.1038/gt.2008.23

26 November 2017

0 references

cites work

AAV-mediated gene delivery of BDNF or GDNF is neuroprotective in a model of Huntington disease

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.23

Brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4/5 prevent the death of striatal projection neurons in a rodent model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.23

Brain-derived neurotrophic factor-mediated protection of striatal neurons in an excitotoxic rat model of Huntington's disease, as demonstrated by adenoviral gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.23

Structural and functional neuroprotection in a rat model of Huntington's disease by viral gene transfer of GDNF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.23

Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.23

Lentiviral gene delivery of GDNF into the striatum of R6/2 Huntington mice fails to attenuate behavioral and neuropathological changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.23

Cellular delivery of human CNTF prevents motor and cognitive dysfunction in a rodent model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.23

Restoration of cognitive and motor functions by ciliary neurotrophic factor in a primate model of Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.23

Neuroprotective effect of a CNTF-expressing lentiviral vector in the quinolinic acid rat model of Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.23

Brain-derived neurotrophic factor in Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.23

Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.23

Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.23

Progressive loss of BDNF in a mouse model of Huntington's disease and rescue by BDNF delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.23

Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.23

Mutant huntingtin impairs the post-Golgi trafficking of brain-derived neurotrophic factor but not its Val66Met polymorphism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.23

Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.23

Neurotrophins and activity-dependent plasticity of cortical interneurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.23

Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.23

Brain-derived neurotrophic factor modulates dopaminergic deficits in a transgenic mouse model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.23

Differential effects of voluntary physical exercise on behavioral and brain-derived neurotrophic factor expression deficits in Huntington's disease transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.23

Environmental enrichment rescues protein deficits in a mouse model of Huntington's disease, indicating a possible disease mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.23

Brain-derived neurotrophic factor restores synaptic plasticity in a knock-in mouse model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.23

Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.23

Anticonvulsant and antiepileptogenic effects mediated by adeno-associated virus vector neuropeptide Y expression in the rat hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.23

Differential expression of inducible transcription factors in basal ganglia neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.23

Basal expression of the inducible transcription factors c-Jun, JunB, JunD, c-Fos, FosB, and Krox-24 in the adult rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.23

The Corridor Task: a simple test of lateralised response selection sensitive to unilateral dopamine deafferentation and graft-derived dopamine replacement in the striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.23

Rotational behaviour in rats with unilateral striatal kainic acid lesions: a behavioural model for studies on intact dopamine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.23

Generation and characterization of chimeric recombinant AAV vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.23

Brain-derived neurotrophic factor transgenic mice exhibit passive avoidance deficits, increased seizure severity and in vitro hyperexcitability in the hippocampus and entorhinal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.23

Characteristics of BDNF-induced weight loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.23

BDNF regulates eating behavior and locomotor activity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.23

Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.23

Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.23

The organization of the projection from the cerebral cortex to the striatum in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.23

The neostriatal mosaic. I. Compartmental organization of projections from the striatum to the substantia nigra in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.23

Mechanisms of adeno-associated virus genome encapsidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.23

Verification of functional AAV-mediated neurotrophic and anti-apoptotic factor expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.23

Protection of the neostriatum against excitotoxic damage by neurotrophin-producing, genetically modified neural stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.23

7 January 2021

Implants of encapsulated human CNTF-producing fibroblasts prevent behavioral deficits and striatal degeneration in a rodent model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.23

7 January 2021

Corticostriatopallidal neuroprotection by adenovirus-mediated ciliary neurotrophic factor gene transfer in a rat model of progressive striatal degeneration

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.23

7 January 2021

https://api.crossref.org/works/10.1038%2FGT.2008.23

1 reference

7 January 2021

CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.23

7 January 2021

Hyperexcitability in combined entorhinal/hippocampal slices of adult rat after exposure to brain-derived neurotrophic factor.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.23

7 January 2021

Targeted retrograde gene delivery for neuronal protection

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.23

7 January 2021

Identifiers

DOI

10.1038/GT.2008.23

1 reference

PubMed ID

18323792

Dimensions Publication ID

26 November 2017

0 references

1 reference

PubMed ID

18323792